Changes in sclerostin, dickkopf-1 and serum markers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with adalimumab.

Susanne Juhl Pedersen, Inge Juul Sørensen, Julia Sidenius Johansen, P. Garnero, A.G. Loft, J. Skjødt, Gorm Milan Thamsborg, K. Asmussen, E. Kluger, J. Nørregaard, T.G. Christensen, Mikkel Østergaard

    Original languageEnglish
    JournalArthritis & Rheumatism
    Volume64
    Issue number10 suppl.
    Pages (from-to)S253
    Number of pages1
    ISSN0004-3591
    Publication statusPublished - 2012

    Cite this